Peptide LocalCompare price, evidence & access
Search /Compare vendors
Regions/Global status checker
One name + one destination

Peptide status
by country.

Check whether a name resolves to a research listing, investigational program, or approved medicine, then open the exact product and seller records for the destination country.

Identity+Destination=Verification route
41tracked names
42country guides
3separate evidence lanes
99official source routes
Global source router

Two selections. No category shortcuts.

Start with a peptide name and destination. The result shows what the name means in our evidence database and which local records must be checked next.

Status check updated to Ecnoglutide in 中国. NMPA-approved medicine in China.

Current source route

Ecnoglutide in 中国

Open exact country guide
Direct answer / 中国

Can you buy Ecnoglutide in 中国?

NMPA-approved medicine in China

Ecnoglutide injection has NMPA approvals in China for adult type 2 diabetes and chronic weight management in Chinese adults with overweight or obesity. The exact presentation, current product status, authorization holder, seller identity, and supply route still need to match current Chinese records.

  1. 01
    Resolve the nameClinical pipeline profile
  2. 02
    Check 中国China NMPA medicine approval
  3. 03
    Verify the exact offerProduct, seller, and supply route must match
Identity recordChina-approved medicine and active development program

What Ecnoglutide resolves to

Ecnoglutide injection has NMPA approvals in China for adult type 2 diabetes and chronic weight management in Chinese adults with overweight or obesity. Those China-specific approvals do not establish FDA approval, authorization in another country, or the identity and authority of an online seller.

Evidence lane
Clinical pipeline profile
Current record
China approvals active; indication-expansion studies continue
Checked
July 18, 2026
XW003Sciwind ecnoglutidecAMP-biased GLP-1 receptor agonist埃诺格鲁肽
Destination record必须按具体产品与经营主体分别核验

What 中国 still has to prove

本指南面向在中国搜索肽类、多肽药物、减重药物和研究材料的用户，提供以国家药品监督管理局药品数据和国家企业信用信息公示系统为起点的核验路径。它将具体药品批准、批准持有人、剂型规格、企业登记和网络供应声明分开处理，避免把名称相同、中文页面、人民币价格或境内发货承诺误当成产品已经获批或卖方已经验证的证据。

Comparison mode
人民币 / 药品批准与企业登记记录
Price coverage
暂无符合发布标准的中国卖方价格表
Guide updated
2026年7月18日
Product record国家药品监督管理局数据查询国家药品监督管理局 ↗Seller or supply record国家企业信用信息公示系统国家市场监督管理总局 ↗
Country-specific evidence found2 records attached to this exact check
Result boundaryIdentity match ≠ destination approval ≠ verified seller

This check routes each question to the right record. It is not a medical recommendation, legal opinion, local availability claim, or commercial ranking.

Popular starting points

Open a common peptide and country check.

Each selection has a shareable URL, so you can send someone the exact peptide and destination without losing the identity or country context.

01CagriSema in South AfricaInvestigational clinical program02CagriSema in PortugalInvestigational clinical program03Retatrutide in ArgentinaInvestigational clinical program04Melanotan II in ItaliaUS research-market identity05PT-141 / Bremelanotide in ItaliaUS research-market identity with a separate FDA-approved medicine record06CJC-1295 DAC in FranceUS research-market identity07BPC-157 in FranceUS research-market identity08BPC-157 in DeutschlandUS research-market identity09Retatrutide in MéxicoInvestigational clinical program10Mazdutide in 中国China-approved medicine and active clinical program11Ecnoglutide in 中国China-approved medicine and active development program12Enicepatide in FranceInvestigational clinical program13Eloralintide in DeutschlandInvestigational clinical program14Tirzepatide in CanadaUS FDA medicine reference15Cagrilintide in United KingdomInvestigational clinical program16Petrelintide in DeutschlandInvestigational clinical program17MariTide in AustraliaInvestigational clinical program18Survodutide in FranceInvestigational clinical program19VK2735 in United StatesInvestigational clinical program20Pemvidutide in United StatesInvestigational clinical program21Semaglutide in الإمارات العربية المتحدةProduct-specific approved medicine records in multiple jurisdictions22Semaglutide in FranceProduct-specific approved medicine records in multiple jurisdictions23Semaglutide in CanadaProduct-specific approved medicine records in multiple jurisdictions24TB-500 in United StatesUS research-market identity25TB-500 in CanadaUS research-market identity26GHK-Cu in CanadaUS research-market identity27Semax in South AfricaUS research-market identity28Melanotan II in AustraliaUS research-market identity29MOTS-c in CanadaUS research-market identity30Tesamorelin in United StatesUS research-market identity with a separate FDA-licensed medicine record31AOD-9604 in South AfricaUS research-market identity with a failed oral obesity program and no FDA-approved drug32Ipamorelin in CanadaUS research-market identity33Selank in South AfricaUS research-market identity34PT-141 / Bremelanotide in United StatesUS research-market identity with a separate FDA-approved medicine record35CJC-1295 no DAC in CanadaUS research-market identity36CJC-1295 DAC in South AfricaUS research-market identity
Direct answers

What a country check means.

The short answer is a routing decision, not a blanket legal, medical, or availability conclusion.

01

Is BPC-157 legal in every European country?

No region-wide answer is supportable from a seller page or a single database. Resolve the BPC-157 identity, choose the exact destination, then check that country’s product and seller or supply records.

02

Is retatrutide available as an approved medicine?

The Peptide Local identity record places retatrutide in the investigational clinical-program lane. A seller-labelled vial cannot inherit the sponsor’s trial material, evidence, or regulatory status.

03

Does a tirzepatide record prove local availability?

No. The FDA reference resolves the US medicine identity. Authorization, presentation, prescription status, current market presence, and seller authority must still be confirmed in the selected country.

Why the split matters

A matching name is only the first record.

  1. 01

    Resolve identity

    Keep the active ingredient, research label, clinical program, sponsor code, and approved brand attached to their proper source.

  2. 02

    Resolve destination

    Open the national product database and the separate pharmacy, establishment, professional, seller, or supply record linked for that country.

  3. 03

    Resolve the exact offer

    Match the legal seller identity, product presentation, claimed category, current status, and delivery route. Do not transfer evidence between unlike products.

Continue the evidence trail
Search the complete peptide database ↗Compare all five world regions ↗Open all country, province, state, region, and city guides ↗